Vitamin D has proven to aid in the treatment of many health conditions.
However, researchers are driven to uncover if this vitamin is beneficial
in treating cancer.
At a national conference researchers debated over whether or not
plain vitamin D worked more effectively than a potentially profitable
form of vitamin D, specifically designed to treat cancer.
Some questions researchers hoped to find
answers to included:
- Should patients take supplemental vitamin D in addition to
the standard cancer treatment?
- Should patients be treated for vitamin D deficiency?
However, in the midst of these questions, the discussion took a
turn and boiled down to one main focal point: calcitriol.
Calcitriol, the most potent steroid hormone in the human body,
is produced in large amounts in the tissues of vitamin D-filled
individuals. However, in patients with cancer, vitamin D is in low
supply. It is for this reason that some researchers proposed to
develop an analogues form of this vitamin to fill up those patients'
tanks.
For these reasons, most believe vitamin D should without a doubt
be given to cancer patients, in addition to the standard cancer
treatment. This theory here is that the vitamin D will significantly
increase tissue levels of calcitriol, which in turn has outstanding
anticancer properties.
A downfall to this theory is that intravenous calcitriol and its
analogues cause hypocalcaemia, or high blood calcium. Plain vitamin
D does not have this problem.
Reports have shown that plain vitamin
D helps with the following types of cancer:
- Colon
- Prostate
- Pancreatic
- Breast, ovarian and cervical
The studies concluded that vitamin D analogues may help certain
types of cancer, but it does not provide a cure, nor it will not
treat vitamin D deficiency. Researchers agreed that the best route
to fighting cancer is to have a sufficient intake of natural vitamin
D to create more calcitriol.
In addition, plain vitamin D may also help prevent normal cells
from turning cancerous. Vitamin D nutrition may also help common
health-conditions linked to cancer such as hypertension, type 2
diabetes, heart disease, chronic pain and osteoporosis.
Medical
News Today October 11, 2004
|